8-Methoxyquinolines as PDE4 inhibitors.

Billah, Motasim; Buckley, George M; Cooper, Nicola; Dyke, Hazel J; Egan, Robert; Ganguly, Ashit; Gowers, Lewis; Haughan, Alan F; Kendall, Hannah J; Lowe, Christopher; Minnicozzi, Michael; Montana, John G; Oxford, Janet; Peake, Joanna C; Picken, C Louise; Piwinski, John J; Naylor, Robert; Sabin, Verity; Shih, Neng-Yang; Warneck, Julie B H

Billah, Motasim; Buckley, George M; Cooper, Nicola; Dyke, Hazel J; Egan, Robert; Ganguly, Ashit; Gowers, Lewis; Haughan, Alan F; Kendall, Hannah J; Lowe, Christopher; Minnicozzi, Michael; Montana, John G; Oxford, Janet; Peake, Joanna C; Picken, C Louise; Piwinski, John J; Naylor, Robert; Sabin, Verity; Shih, Neng-Yang; Warneck, Julie B H.

Affiliation

Billah M; Schering-Plough Corporation, Galloping Hill Road, Kenilworth, NJ 07033-0530, USA.

Bioorg Med Chem Lett ; 12(12): 1617-9, 2002 Jun 17.

Article in En | MEDLINE | ID: mdl-12039575

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Phosphodiesterase Inhibitors / Quinolines / 3',5'-Cyclic-AMP Phosphodiesterases Type of study: Prognostic_studies Limits: Animals Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2002 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Search on Google

Add to My VHL

XML

PubMed Links